SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+11.29%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$231M
AUM Growth
+$231M
(-23%)
Cap. Flow
-$89.5M
Cap. Flow
% of AUM
-38.7%
Top 10 Holdings %
Top 10 Hldgs %
95.34%
Holding
23
New
–
Increased
5
Reduced
11
Closed
7
Top Buys
| 1 |
Evolus
EOLS
|
$1.62M |
| 2 |
ADMA Biologics
ADMA
|
$535K |
| 3 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$68.1K |
| 4 |
Xeris Biopharma Holdings
XERS
|
$50.8K |
| 5 |
AYTU BioPharma
AYTU
|
$284 |
Top Sells
| 1 |
Galapagos
GLPG
|
$22M |
| 2 |
QuidelOrtho
QDEL
|
$15.4M |
| 3 |
MaxCyte
MXCT
|
$11.7M |
| 4 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$8.2M |
| 5 |
ATYR
aTyr Pharma
ATYR
|
$5.84M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Evolus
EOLS
$494M
| $56.2M | 24.29% | 5,333,004 +154,000 | +3% | +$1.62M |
|
|
2
ADMA Biologics
ADMA
$4.12B
| $41.7M | 18.03% | 9,222,617 +118,342 | +1% | +$535K |
|
3
Amylyx Pharmaceuticals
AMLX
$836M
| $36.8M | 15.92% | 2,500,000 -15,868 | -0.6% | -$234K |
|
|
4
QuidelOrtho
QDEL
$1.95B
| $33.2M | 14.34% | 450,000 -208,794 | -32% | -$15.4M |
|
|
ALIM
5
DELISTED
Alimera Sciences, Inc.
ALIM
| $17.3M | 7.47% | 3,999,459 +15,773 | +0.4% | +$68.1K |
|
|
6
Xeris Biopharma Holdings
XERS
$1.26B
| $14M | 6.03% | 5,937,000 +21,628 | +0.4% | +$50.8K |
|
|
7
Galapagos
GLPG
$2.07B
| $10.6M | 4.6% | 261,870 -540,674 | -67% | -$22M |
|
8
Xoma
XOMA
$392M
| $4.63M | 2% | 250,000 -186,602 | -43% | -$3.45M |
|
9
IO Biotech
IOBT
$104M
| $3.13M | 1.35% | 1,666,037 -309,271 | -16% | -$581K |
|
10
SCYNEXIS
SCYX
$34.9M
| $3.02M | 1.31% | 1,355,186 -1,497,413 | -52% | -$3.34M |
|
11
Rezolute
RZLT
$619M
| $2.75M | 1.19% | 2,768,656 -303,820 | -10% | -$302K |
|
12
Atea Pharmaceuticals
AVIR
$267M
| $2.56M | 1.11% | 839,514 -880,486 | -51% | -$2.69M |
|
13
TELA Bio
TELA
$70.5M
| $2.1M | 0.91% | 317,782 -174,137 | -35% | -$1.15M |
|
|
14
AYTU BioPharma
AYTU
$21.1M
| $1.34M | 0.58% | 472,469 +100 | +0% | +$284 |
|
15
Exagen
XGN
$217M
| $1.33M | 0.58% | 669,684 -533,807 | -44% | -$1.06M |
|
|
ATYR
16
aTyr Pharma
ATYR
$527M
| $680K | 0.29% | 482,258 -4,144,366 | -90% | -$5.84M |
|
17
Assertio
ASRT
$80.4M
| – | – | -951,197 | Closed | -$2.44M |
|
18
Delcath Systems
DCTH
$385M
| – | – | -686,240 | Closed | -$2.78M |
|
19
Gossamer Bio
GOSS
$562M
| – | – | -3,339,405 | Closed | -$2.78M |
|
|
20
MaxCyte
MXCT
$148M
| – | – | -3,761,640 | Closed | -$11.7M |
|
21
Vanda Pharmaceuticals
VNDA
$279M
| – | – | -477,903 | Closed | -$2.06M |
|
22
X4 Pharmaceuticals
XFOR
$84.2M
| – | – | -5,273,685 | Closed | -$5.75M |
|
|
GMDA
23
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| – | – | -7,965,865 | Closed | -$8.2M |
|